Generali Asset Management SPA SGR purchased a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) during the second quarter, HoldingsChannel.com reports. The fund purchased 22,156 shares of the company’s stock, valued at approximately $1,641,000.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Bessemer Group Inc. raised its holdings in shares of GE HealthCare Technologies by 24.3% in the first quarter. Bessemer Group Inc. now owns 6,671 shares of the company’s stock valued at $538,000 after purchasing an additional 1,306 shares during the last quarter. Flagship Harbor Advisors LLC raised its holdings in shares of GE HealthCare Technologies by 17.4% in the first quarter. Flagship Harbor Advisors LLC now owns 3,443 shares of the company’s stock valued at $278,000 after purchasing an additional 511 shares during the last quarter. Lineweaver Wealth Advisors LLC acquired a new stake in shares of GE HealthCare Technologies in the second quarter valued at approximately $592,000. Wealth Enhancement Advisory Services LLC increased its holdings in GE HealthCare Technologies by 23.8% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 50,859 shares of the company’s stock worth $4,105,000 after buying an additional 9,769 shares during the last quarter. Finally, Exome Asset Management LLC acquired a new position in GE HealthCare Technologies during the first quarter worth $2,050,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
GEHC has been the topic of a number of recent analyst reports. Citigroup downgraded shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $93.00 to $83.00 in a report on Tuesday, October 7th. BTIG Research boosted their target price on shares of GE HealthCare Technologies from $87.00 to $89.00 and gave the stock a “buy” rating in a report on Monday. Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a report on Thursday, September 18th. Barclays initiated coverage on shares of GE HealthCare Technologies in a report on Monday. They set an “equal weight” rating and a $86.00 target price on the stock. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Tuesday. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $85.20.
GE HealthCare Technologies Trading Up 0.9%
GEHC stock opened at $74.05 on Friday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. The company has a fifty day moving average price of $74.51 and a two-hundred day moving average price of $72.08. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The stock has a market cap of $33.81 billion, a price-to-earnings ratio of 15.17, a price-to-earnings-growth ratio of 2.80 and a beta of 1.13.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.15. The company had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. GE HealthCare Technologies’s quarterly revenue was up 3.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.
GE HealthCare Technologies Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s payout ratio is presently 2.87%.
About GE HealthCare Technologies
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Stories
- Five stocks we like better than GE HealthCare Technologies
- Stock Sentiment Analysis: How it Works
- This AI Chip Giant Could Be the Market’s Next Big Winner
- What Are Dividend Challengers?
- Broadcom Inks OpenAI Deal: Why It’s A Huge Win for AVGO Stock
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Institutions Are Fueling CrowdStrike’s Next Leg Higher
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.